Given that VHL mutations are remarkably specific for ccRCC12,13, this suggested the possibility that high HIF2A mRNA expression levels in ccRCC may modulate the potential at which VHL loss promotes tumorigenesis. This evidence concerns the gene EPAS1 and nonpapillary renal cell carcinoma.